Here is the transcript of the FDA talk paper concerning
*colloidal silver*. You will notice that the definition of
colloidal silver is a silver suspension in a gelatinous base, or
as we know it an MSP.
They do not refer to the suspension of silver in distilled water
at all.
This is probably an attempt to damn by association and confusion.
It would be a small step for them to amend the definition.
Maybe it is a good sign, that there is no evidence of danger or
ineffectiveness of CS.
Perhaps we need to rename our product to 'Silver Sol' which is
the colloidal suspension of silver in water?
Regards - Ivan
T99-39 Print Media: 301-827-6242
August 17, 1999 Broadcast Media: 301-827-3434
Consumer Inquiries: 888-INFO-FDA
FDA ISSUES FINAL RULE ON
OTC DRUG PRODUCTS CONTAINING COLLOIDAL SILVER
The FDA has issued a Final Rule declaring that all over-
the-counter (OTC) drug products containing colloidal silver or
silver salts are not recognized as safe and effective and are
misbranded.
Colloidal silver is a suspension of silver particles in a
colloidal (gelatinous) base. In recent years, colloidal silver
preparations of unknown formulation have been appearing in
stores. These products are labeled to treat adults and children
for diseases including HIV, AIDS, cancer, tuberculosis, malaria,
lupus, syphilis, scarlet fever, shingles, herpes, pneumonia,
typhoid, tetanus and many others.
According to the Final Rule, a colloidal silver product for any
drug use will first have to be approved by FDA under the new drug
application procedures. The Final rule classifies colloidal
silver products as misbranded because adequate directions cannot
be written so that the general public can use these drugs safely
for their intended purposes. They are also misbranded when their
labeling falsely suggests that there is substantial scientific
evidence to establish that the drugs are safe and effective for
their intended uses.
The indiscriminate use of colloidal silver solutions has resulted
in cases of argyria, a permanent blue-gray discoloration of the
skin and deep tissues.
Colloidal silver ingredients and silver salts include silver
proteins, mild silver protein, strong silver protein, silver
chloride, and silver iodide. The dosage form of these colloidal
silver products is usually oral, but product labeling also
contains directions for topical and, occasionally, intravenous
use.
In reaching its decision, FDA considered all of the information
described in the proposed rule (October 15, 1996) and submitted
by the public in response to that proposal, the Final Rule
becomes effective on September 16, 1999, 30 days after
publication.
####
--
The silver-list is a moderated forum for discussion of colloidal silver.
To join or quit silver-list or silver-digest send an e-mail message to:
[email protected] -or- [email protected]
with the word subscribe or unsubscribe in the SUBJECT line.
To post, address your message to: [email protected]
List maintainer: Mike Devour <[email protected]>
